Organisation
Hepatology
Division
The labo of Hepatology studies pathophysiology and treatment of liver and pancreas diseases and metabolism.
Current researchers
1 - 10 of 14 results
- Schalk Van der Merwe (Responsible)
- Isabelle Adant (Member)
- David Cassiman (Member)
- Rita Furtado Feio De Azevedo (Member)
- Hannelie Korf (Member)
- Wim Laleman (Member)
- Louis Libbrecht (Member)
- Frederik Nevens (Member)
- Lukas Van Melkebeke (Member)
- Marc Van de Casteele (Member)
Projects
1 - 10 of 48
- Harnessing Single-Cell and Spatial Transcriptomics to Uncover Novel Insights into Intestinal Barrier Breach in CirrhosisFrom1 Oct 2023 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Deciphering the molecular mechanism that account for intestinal barrier dysfunction in cirrhosisFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Harnessing single-cell and spatial transcriptomics to uncover novel insights into the pathological events that trigger the progression of acute-on-chronic liver failureFrom1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validation and implementation of a prognostic biomarker of early graft failure after liver transplantation (GlycoTransplantTest)From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Model-informed Dose Optimization of Immunosuppressants in Solid Organ Transplant PatientsFrom27 Jul 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Design of robotic catheter and endoscopic systems for cancer treatmentFrom16 Feb 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stratifying risk and individualizing care for patients with clinically significant portal hypertension (CSPH)From7 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metabolic rewiring in SORDD polyneuropathy: unraveling a polyol pathway disorderFrom1 Oct 2021 → TodayFunding: FWO fellowships
- Liver transplantation for alcohol-related liver disease.From23 Jun 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Therapeutic endoscopic ultrasound: where are we and where do we go?From16 Mar 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 1260
- norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response(2016)
Authors: Michael H Trauner, Peter Fickert, Gideon Hirschfield, Gerald Denk, Istvan Altorjay, Hanns-Ulrich Marschall, Martti A Färkilä, Christoph Schramm, Ulrich Spengler, Roger W Chapman, et al.
Pages: 111A - 111A - SHORT-TERM (28-DAY) CLINICAL COURSE AND TRANSPLANT-FREE MORTALITY IN ACUTE ON CHRONIC LIVER FAILURE (ACLF); EVIDENCE FOR REVERSIBILITY OF ACLF (A STUDY FROM THE CANONIC DATABASE)(2014)
Authors: T Gustot, J Fernandez, E Garcia, P Gines, R Moreau, R Jalan, M Pavesi, F Durand, P Angeli, P Caraceni, et al.
Pages: S228 - S228 - DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY(2012)
Authors: R Moreau, P Gines, R Jalan, M Pavesi, F Durand, P Angeli, P Caraceni, G Pereira, C Hopf, C Alessandria, et al.
Pages: S552 - S553 - Long-Term Superior Renal Function With Everolimus and Reduced Tacrolimus in Liver Transplant Recipients: 3-Year Results from the H2304 Extension Study(2014)
Authors: Lutz Fischer, Faouzi Saliba, Gernot M Kaiser, Luciano De Carlis, Herold J Metselaar, Frederik Nevens, Christophe Duvoux, Gaohong Dong, Barbara Rauer, Guido Junge
Pages: S171 - S172 - Sustained Improvement in the Markers of Cholestasis in an Open Label Long Term Safety Extension Study of Obeticholic Acid in Primary Biliary Cirrhosis Patients(2015)
Authors: Michael Trauner, Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, Simone I Strasser, Christopher L Bowlus, Pietro Invernizzi, Joost Drenth, Paul J Pockros, Jaroslaw Regula, et al.
Pages: 511A - 512A - EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANTATION: 3-YEAR RESULTS FROM H2304 STUDY EXTENSION(2014)
Authors: F Saliba, GM Kaiser, L De Carlis, HJ Metselaar, P De Simone, C Duvoux, Frederik Nevens, L Fischer, J Fung, G Dong, et al.
Pages: S362 - S362 - HIGH-THROUGHPUT ANALYSIS OF AN ETIOLOGY DRIVEN DUCTULAR REACTION AND ITS NICHE IN ACUTE AND CHRONIC LIVER INJURY(2019)
Authors: Matthias Van Haele, Tim Dierckx, Mohammed Benkheil, Olivier Govaere, Frederik Nevens, Tania Roskams
Pages: 1110A - 1110A - Central role of c-Myc during malignant conversion in human hepatocarcinogenesis (vol 69, pg 2775, 2009)(2009)
Authors: P Kaposi-Novak, Louis Libbrecht, HG Woo, Y-H Lee, NC Sears, Cedric Coulouarn, EA Conner, VM Factor, T Roskams, SS Thorgeirsson
Pages: 3721 - 3721 - The GLOBE score indentifies PBC patients at increased risk of liver transplantation during follow-up(2016)
Authors: Jorn C Goet, Willem J Lammers, Harry L Janssen, Gideon M Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, Maria Pier Battezzati, Frederik Nevens, et al.
Pages: 189A - 190A - False-negative tests in breast cancer management(2011)
Authors: Karin Leunen, Joannes Menten, Werner Van Steenbergen, Patrick Neven
Pages: 324 - 329